Fierce Pharma

SEPTEMBER 20, 2024

After more than a decade without any therapeutic advancements in chronic obstructive pulmonary disorder (COPD), people with the progressive disease suddenly have two new options, with more likely o | Regeneron and Sanofi have announced that the FDA has expanded the label of megablockbuster Dupixent to treat COPD. With the nod, Dupixent becomes the first biologic treatment for COPD patients in the U.S.

FDA 311

FDA Patients 311

MedCity News

SEPTEMBER 20, 2024

Zevra Therapeutics drug Miplyffa is now FDA approved for Niemann-Pick disease type C, a lysosomal storage disorder. The affirmative regulatory decision took into account additional clinical data generated since the FDA turned down a submission for the drug in 2021. The post FDA Approval Makes a Zevra Drug the First Therapy for Rare and Fatal Metabolic Disease appeared first on MedCity News.

FDA 116

FDA Biopharma Pharma 116

Fierce Pharma

SEPTEMBER 20, 2024

The hits just keep on coming for Bristol Myers Squibb staffers amid the company's cost-savings program. | Bristol Myers Squibb is laying off an additional 79 staffers in Lawrenceville, New Jersey. The cuts will be effective between Dec. 12 and May 30 of next year and are part of BMS's $1.5 billion cost reduction program.

289

289

MedCity News

SEPTEMBER 20, 2024

We need to continue investing in research for early stage, localized prostate cancer, develop treatments that balance efficacy with quality-of-life considerations, ensure diverse representation in clinical trials, and listen to patients and incorporate their perspectives into treatment development and decision-making. The post Prostate Cancer Management – We Need Better Options for Early-Stage Disease appeared first on MedCity News.

Management 110

Management Patients Physicians 110

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

SEPTEMBER 20, 2024

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on AstraZeneca's influenza vaccine FluMist for self-administration by adults up to 49 years old and for administration by a parent or caregiver in kids between the ages of 2 and 17. With the green light, FluMist is now the only flu vaccine in the U.S. patients can give to themselves.

FDA 272

FDA Patients 272

MedCity News

SEPTEMBER 20, 2024

Many are already experimenting with AI in narrow settings. But in order to expand deployment, it’s important to understand the most practical AI opportunities with the greatest ROI. Here are four high-impact opportunities that can boost staff efficiency and improve the patient experience. The post From Charting to Patient Intake: The 4 Biggest Opportunities for AI in Healthcare appeared first on MedCity News.

Healthcare 114

Healthcare Healthcare Patients 114

MedCity News

SEPTEMBER 20, 2024

Meditech is integrating Suki’s AI assistant into more than a dozen rural health systems, including St. Mary’s Healthcare in New York and Decatur County Memorial Hospital in Indiana. The post When It Comes to AI, Rural Doctors Have FOMO — Meditech & Suki Are Teaming Up to Address This appeared first on MedCity News.

Doctors 108

Doctors Healthcare Healthcare 108

Fierce Pharma

SEPTEMBER 20, 2024

Amid a parade of regulatory endorsements in Europe, Apellis Pharmaceuticals’ ophthalmology prospect pegcetacoplan has been left in the cold once again. | Europe’s Committee for Medicinal Products for Human Use has confirmed its negative stance on pegcetacoplan in geographic atrophy, an advanced form of age-related macular degeneration that can lead to blindness.

Prospecting 259

Prospecting Medicine Leads Pharmaceutical 259

MedCity News

SEPTEMBER 20, 2024

In two letters, U.S. representatives and senators called for an extension of the enhanced premium tax credits, which are set to expire in 2025 and have lowered costs for those purchasing coverage on the marketplace. The post 195 Congress Members Call for Extension of Enhanced Premium Tax Credits appeared first on MedCity News.

107

107

Fierce Pharma

SEPTEMBER 20, 2024

For Zevra Therapeutics and its rare neurodegenerative disease med arimoclomol, the second time’s the charm. | The FDA approved Zevra’s arimoclomol capsules to treat the rare lysosomal storage disorder Niemann-Pick disease type C in conjunction with Johnson & Johnson’s enzyme inhibitor miglustat. Arimoclomol, which will fly under the brand name Miplyffa, is now the first FDA-approved therapy for NPC.

FDA 250

FDA 250

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Pharmaceutical Technology

SEPTEMBER 20, 2024

The growth of AI in the healthcare sector is already having real-world impacts and promises a step-change in future care.

Healthcare 115

Healthcare Healthcare 115

Fierce Pharma

SEPTEMBER 20, 2024

Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. That changed Friday. | Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. That changed Friday.

FDA 235

FDA Patients 235

pharmaphorum

SEPTEMBER 20, 2024

Astellas is ready to launch its first digital health product in the US, called Digitiva, which provides at-home monitoring of people with heart failure

106

106

Fierce Pharma

SEPTEMBER 20, 2024

Fierce Pharma Asia—Merck's collabs with Daiichi, Eisai deliver readouts; Granules hit with FDA manufacturing observations aliu Fri, 09/20/2024 - 09:21

Manufacturing 195

Manufacturing Pharma FDA 195

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

MedCity News

SEPTEMBER 20, 2024

Active investors chose Healthy Young Minds as the Pitch Perfect winner at the INVEST Digital Health Conference in Dallas. See how the company’s CEO accepted the award. The post Video: INVEST Digital Health Pitch Perfect Winner Accepting Award appeared first on MedCity News.

95

95

Pharmaceutical Technology

SEPTEMBER 20, 2024

The biotech has secured $65m in a Series A funding round led by Cormorant Asset Management and other investors.

Management 105

Management 105

pharmaphorum

SEPTEMBER 20, 2024

J&J's target of $5bn in sales for Rybrevant has moved a step closer, after an FDA approval for second-line treatment of EGFR+ NSCLC

FDA 92

FDA Sales 92

PharmaTech

SEPTEMBER 20, 2024

Hayley Crowe, executive vice-president and general manager Global Life Sciences at Ecolab discussed at BIO 2024 how technology innovations have enhanced downstream bioprocessing.

Manufacturing 52

Manufacturing Management 52

Advertisement

Pharmaceutical Commerce

SEPTEMBER 20, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Kevin MacDonald, Bluesight’s Co-founder and CEO, discusses why mitigating the impact of rising costs is imperative, while explaining the benefit of advanced analytics tools.

Pharma 52

Pharma 52

PharmaTech

SEPTEMBER 20, 2024

The announcement of the pairing comes several months after Adare Pharma Solutions said it would upgrade several of its facilities, including in Milan, Italy, where the 3D printing operations will be located.

Pharma 52

Pharma 52

PharmExec

SEPTEMBER 20, 2024

Rybrevant is the first targeted second-line regimen to significantly reduce the risk of disease progression by more than 50% in patients with locally advanced or metastatic EGFR mutated non-small cell lung cancer, according to Johnson & Johnson.

FDA 52

FDA Patients 52

PharmaTech

SEPTEMBER 20, 2024

In this video, hear Albert McEvoy, Senior Director of NORAM Logistics, talk about how Marken is preparing its pharma supply chains for a new age of healthcare by optimizing drug development and delivery through cutting-edge tech, strategic partnerships, and contingency plans ― a future where patients anywhere in the world have access to essential medicines.

Pharma 52

Pharma Medicine Healthcare Healthcare 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PM360

SEPTEMBER 20, 2024

LONDON, September 20, 2024 – The Creative Floor Healthcare Awards, celebrated the world’s best health and wellness creative work, agency talent and clients yesterday at its 11th year extravaganza in London. Klick Health won the Most Awarded Agency, IPG Health won the Most Awarded Network and Tim Hawkey from Area 23 picked up the inaugural Hall of Legends crimson-blood award.

Healthcare 52

Healthcare Healthcare Specialization Networking 52

PharmaTech

SEPTEMBER 20, 2024

The collaboration is designed to combine NanoVation Therapeutics’ lipid nanoparticle technology for RNA delivery to cells outside the liver with Novo Nordisk’s knowledge of cardiometabolic and rare disease R&D.

Medicine 52

Medicine 52

PharmaVoice

SEPTEMBER 20, 2024

Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment. But the long-awaited move won’t cure all that ails the sector, others cautioned.

52

52

PharmaTech

SEPTEMBER 20, 2024

Vectura’s expertise in the field includes formulation and device development for dry powder inhalers and pressurized metered dose inhalers, among other products and services.

52

52

Advertisement

Distribution

PharmaVoice

SEPTEMBER 20, 2024

A promising epilepsy drug Ovid sold to Takeda recently missed the mark in late-stage trials. But Ovid believes it has other novel mechanisms that could deliver a CNS win.

52

52

Pharmaceutical Technology

SEPTEMBER 20, 2024

In this issue: Solving adherence issues with prodrugs, examining whether PBMs are to blame for high drugs prices in the US, developing vaccines for Disease X, and more.

52

52

PharmExec

SEPTEMBER 20, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Medical 52

Medical Pharma 52

Pharmaceutical Technology

SEPTEMBER 20, 2024

The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended an update to Novo Nordisk’s Wegovy label.

Medicine 52

Medicine 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales